Literature DB >> 16764643

Management of acute rejection 2 years after allogeneic vascularized knee joint transplantation.

M Diefenbeck, F Wagner, M H Kirschner, A Nerlich, T Mückley, G O Hofmann.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16764643     DOI: 10.1111/j.1432-2277.2006.00327.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  6 in total

Review 1.  [Partial and complete joint transplantation with fresh osteochondral allografts-the FLOCSAT concept].

Authors:  C Krettek; J-D Clausen; N Bruns; C Neunaber
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

Review 2.  [Complex joint reconstruction and joint transplantation with the FLOCSAT concept-planning and surgical implementation].

Authors:  C Krettek; J-D Clausen; C Neunaber
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

3.  Knee joint transplantation combined with surgical angiogenesis in rabbits--a new experimental model.

Authors:  Thomas Kremer; Guilherme Giusti; Patricia F Friedrich; Wouter Willems; Allen T Bishop; Goetz A Giessler
Journal:  Microsurgery       Date:  2011-11-24       Impact factor: 2.425

4.  A modified vascularized whole knee joint allotransplantation model in the rat.

Authors:  Mikko Larsen; Patricia F Friedrich; Allen T Bishop
Journal:  Microsurgery       Date:  2010-10       Impact factor: 2.425

Review 5.  [Healing of free vascularized bone allotransplants: optimizing by short-term immunosuppression and host-derived neovascularization].

Authors:  G A Giessler; P F Friedrich; R H Shin; A T Bishop
Journal:  Unfallchirurg       Date:  2009-05       Impact factor: 1.000

6.  A Flow Dynamic Rationale for Accelerated Vascularized Composite Allotransplant Rejection.

Authors:  Nicholas L Robbins; Matthew J Wordsworth; Bijaya K Parida; Bruce Kaplan; Vijay S Gorantla; Col Erik K Weitzel; Warren C Breidenbach
Journal:  Plast Reconstr Surg       Date:  2019-03       Impact factor: 4.730

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.